SCHEMBL3335375

SCHEMBL3335375

O=C(O)C(Cc1ccccc1)C(=O)Nc1nc(-c2ccccc2)cs1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MRE11 P49959 3/20 0.67
ELOVL1 Q9BW60 1/20 0.64
GPR142 Q7Z601 1/20 0.60
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
ROCK1 Q13464 2/20 0.57
PRKACA P17612 1/20 0.57
MAPT P10636 3/20 0.56
ADORA3 P0DMS8 1/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
TP53 P04637 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
HTT P42858 1/20 0.56
HSD17B10 Q99714 1/20 0.56
GSTO1 P78417 1/20 0.55
ROCK2 O75116 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3331466 0.87 PKM (0.65) MRE11ELOVL1GPR142NPC1RAB9A
SCHEMBL13357576 0.84 ROCK1 (0.67) ELOVL1GPR142ROCK1PRKACAMAPT
SCHEMBL12678090 0.82 ELOVL1 (0.60) ELOVL1GPR142NPC1RAB9AROCK1
SCHEMBL9179947 0.82 ELOVL1 (0.60) ELOVL1GPR142NPC1RAB9AROCK1
SCHEMBL29430089 0.81 MRE11 (1.00) MRE11
SCHEMBL21484703 0.81 MRE11 (1.00) MRE11
SCHEMBL2752589 0.80 LMNA (0.68) ELOVL1NPC1RAB9AROCK1MAPT
SCHEMBL21225987 0.79 HDAC6 (0.66) MRE11ELOVL1NPC1RAB9AROCK1
SCHEMBL21225986 0.79 HDAC6 (0.66) MRE11ELOVL1NPC1RAB9AROCK1
SCHEMBL4949871 0.79 HDAC6 (0.66) MRE11ELOVL1NPC1RAB9AROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868604-B1 REGULATION OF PROTEIN SYNTHESIS BY INHIBITION OF EIF4E-EIF4G INTERACTION HARVARD COLLEGE (US) 2014-08-13 EP disclosed
EP-1868604-B1 REGULATION OF PROTEIN SYNTHESIS BY INHIBITION OF EIF4E-EIF4G INTERACTION HARVARD COLLEGE (US) 2014-08-13 EP disclosed
US-8257931-B2 Regulation of protein synthesis PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-09-04 US disclosed
US-8257931-B2 Regulation of protein synthesis PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-09-04 US disclosed
US-8257931-B2 Regulation of protein synthesis PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-09-04 US disclosed
US-20100144805-A1 Regulation of protein synthesis NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-06-10 US disclosed
US-20100144805-A1 Regulation of protein synthesis NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-06-10 US disclosed
US-20100144805-A1 Regulation of protein synthesis NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144805-A1 Regulation of protein synthesis EIF4EBP1, RNMT, NCBP1 MRE11 3878/4885ELOVL1 2824/4885GPR142 4239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.